With experience spanning the biosciences, chemical, and engineering sectors, Brian is a trusted resource for clients navigating complex intellectual property and technology disputes. His work includes representing companies in high‑stakes patent litigation involving biotechnology and biosynthesis, pharmaceuticals, plastics, telecommunications, and LED technologies. Clients value his ability to integrate scientific, regulatory, and legal considerations into cohesive, business‑aligned strategies.
He plays a significant role in supporting biotechnology clients, particularly those innovating in bioengineering and fermentation technologies. With deep experience litigating patents in metabolic engineering and microbial strain development, he translates highly technical concepts into clear, strategic litigation and counseling positions.
His pharmaceutical research and development (R&D) experience informs his advice on pre‑suit strategy, including product selection, portfolio management, formulation development, proposed labeling language, and litigation and regulatory considerations. This scientific and industry foundation helps clients navigate the intersection of scientific development and legal risk. In litigation, clients rely on his ability to streamline discovery, develop case‑dispositive claim construction positions, and collaborate effectively with expert witnesses. He has taken multiple Hatch‑Waxman matters through trial.
Clients in the pharmaceutical and biological sectors also seek his counsel on FDA regulatory strategy. His work includes preparing responses to Citizen Petitions aimed at delaying generic entry, responding to FDA complete response letters for pending ANDAs, and drafting controlled correspondence related to potential exclusivity forfeiture.
His commitment to service extends to an active pro bono practice, where he advises a charitable research foundation on open‑access data and publication policies and assists Afghan refugees in securing humanitarian parole and permanent residency in the United States.
Before attending law school, Brian worked as a formulation development scientist at Caraco Pharmaceutical Laboratories and gained additional experience in active pharmaceutical ingredient and custom intermediate synthesis at Fabbrica Italiana Sintetici S.p.A.
